Articles  |   February 2016
ACE Question
Article Information
Education / CPD / Articles
Articles   |   February 2016
ACE Question
ASA Monitor 02 2016, Vol.80, 70.
ASA Monitor 02 2016, Vol.80, 70.
Which of the following is most likely indicated in the treatment of a patient with fibromyalgia syndrome (FMS)?
Not surprisingly, given that FMS may have multiple etiologies, there is little general agreement on which pharmacological agents are most effective in its treatment. One study that included 114 different rheumatology practices noted that the 214 patients treated for FMS received 74 different medications. Examples of more commonly used drugs include:
Although guaifenesin is commonly touted as a potential therapy on websites, there is no evidence that it is more effective than placebo in the treatment of patients with FMS.
Pregabalin, duloxetine and milnacipran have received approval from the U.S. Food and Drug Administration for treatment of patients with FMS.
Submit a Comment
Submit A Comment

Contributors must reveal any conflict of interest. Comments are moderated.

Affiliation & Institution
I have a potential conflict of interest
Comment Title

This feature is available to Subscribers Only
ASA Member Login or Create an Account ×